Steel Partners submitted a $16.75-per-share cash acquisition offer for InMode, the Israeli RF microneedling and energy-device manufacturer. InMode's board committee is evaluating rival proposals, signaling a competitive auction. InMode's core products—Morpheus8 (fractional RF microneedling) and Lumenis-legacy energy platforms—are installed in thousands of US practices and generate recurring revenue through handpiece sales and service contracts.
Steel Partners Offers to Acquire InMode at $16.75 Per Share; Board Evaluates Rival Bids
PE firm's cash offer for RF microneedling and energy-device leader triggers competitive auction process.

| Ticker | Company | 1-year change |
|---|---|---|
| INMD | InMode Ltd. | +1.0% |
Steel Partners' $16.75 offer for InMode triggers competitive auction for RF microneedling leader.
A PE-backed acquisition typically signals intent to optimize margins, consolidate manufacturing, and pursue aggressive international expansion. For practice owners, acquisition risk centers on handpiece pricing, service-contract terms, and loyalty-program changes post-close. InMode's current installed base and recurring-revenue model make it an attractive platform for financial engineering. Monitor the final bid price and buyer identity—PE ownership often leads to margin compression for practices through higher consumable costs and stricter rebate terms.
Source: original report ↗
Free: recall & rule-change alerts for your practice.
Get the recalls and state-law changes that hit your treatment room, in your inbox — free. Unsubscribe in one click.
Free · weekly · unsubscribe anytime. Privacy.
Stay three moves ahead of every practice in your market.
Knowing it happened is table stakes. Inside MedSpa Pro hands you the play — what each move means for your margins, your license, and your patients, and exactly what to do about it — in a two-minute brief, twice a week. The owners who read it never get blindsided.
Get the edge · $20/moJoin the owners who run ahead of the industry. Cancel anytime, one click.